Westover Capital Advisors, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Westover Capital Advisors, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q4 2021$819,000
-17.5%
29,2000.0%0.24%
-23.5%
Q3 2021$993,000
-16.8%
29,2000.0%0.31%
-18.8%
Q2 2021$1,193,000
+1.4%
29,2000.0%0.38%
-5.4%
Q1 2021$1,176,000
-31.9%
29,2000.0%0.40%
-34.9%
Q4 2020$1,727,000
-3.5%
29,200
-20.7%
0.62%
-15.4%
Q3 2020$1,790,000
-15.9%
36,800
-16.4%
0.74%
-26.4%
Q2 2020$2,129,000
+42.4%
44,000
-18.2%
1.00%
+23.4%
Q1 2020$1,495,00053,8000.81%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders